Renal And Cardiovascular Actions Of 20‐Hydroxyeicosatetraenoic Acid And Epoxyeicosatrienoic Acids

1. Arachidonic acid (AA) is metabolized by cytochrome P450 (CYP)‐dependent pathways to epoxyeicosatrienoic acids (EET) and 20‐hydroxyeicosatetraenoic acid (20‐HETE) in the kidney and the peripheral vasculature.

[1]  A. Hudetz,et al.  Contribution of 20-HETE to vasodilator actions of nitric oxide in the cerebral microcirculation. , 1999, Stroke.

[2]  J. Falck,et al.  20-HETE agonists and antagonists in the renal circulation. , 1999, American journal of physiology. Renal physiology.

[3]  D. Fulton,et al.  Renal cytochrome P450 omega-hydroxylase and epoxygenase activity are differentially modified by nitric oxide and sodium chloride. , 1999, The Journal of clinical investigation.

[4]  J. Mcgiff,et al.  20-HETE and the kidney: resolution of old problems and new beginnings. , 1999, The American journal of physiology.

[5]  R. Roman,et al.  20-Hydroxyeicosatetraenoic acid and renal function in Lyon hypertensive rats. , 1999, European journal of pharmacology.

[6]  H. Schmidt,et al.  The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation. , 1999, Molecular pharmacology.

[7]  K. Tomer,et al.  Molecular Cloning, Enzymatic Characterization, Developmental Expression, and Cellular Localization of a Mouse Cytochrome P450 Highly Expressed in Kidney* , 1999, The Journal of Biological Chemistry.

[8]  J. Falck,et al.  Kinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoform-specific inhibitors. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[9]  A. Nasjletti,et al.  Contribution of endogenous carbon monoxide to regulation of diameter in resistance vessels. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[10]  D. Mount,et al.  Carbon monoxide stimulates the apical 70-pS K+ channel of the rat thick ascending limb. , 1999, The Journal of clinical investigation.

[11]  W. Campbell,et al.  Endothelium-derived hyperpolarizing factors and vascular cytochrome P450 metabolites of arachidonic acid in the regulation of tone. , 1999, Circulation research.

[12]  E. Jacobs,et al.  Airway synthesis of 20-hydroxyeicosatetraenoic acid: metabolism by cyclooxygenase to a bronchodilator. , 1999, The American journal of physiology.

[13]  J. Falck,et al.  Cytochrome P-450 ω-hydroxylase senses O2 in hamster muscle, but not cheek pouch epithelium, microcirculation. , 1999, American journal of physiology. Heart and circulatory physiology.

[14]  R. Roman,et al.  A common pathway for regulation of nutritive blood flow to the brain: arterial muscle membrane potential and cytochrome P450 metabolites. , 1998, Acta physiologica Scandinavica.

[15]  J. Falck,et al.  Nitric oxide-20-hydroxyeicosatetraenoic acid interaction in the regulation of K+ channel activity and vascular tone in renal arterioles. , 1998, Circulation research.

[16]  J. Mcgiff,et al.  Functional response of the rat kidney to inhibition of nitric oxide synthesis: role of cytochrome P450‐derived arachidonate metabolites , 1998, British journal of pharmacology.

[17]  I. Benter,et al.  20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Capdevila,et al.  Molecular, enzymatic, and regulatory characterization of rat kidney cytochromes P450 4A2 and 4A3. , 1998, Biochemistry.

[19]  J. Falck,et al.  Contribution of 20-HETE to the vasodilator actions of nitric oxide in renal arteries. , 1998, American journal of physiology. Renal physiology.

[20]  D. Salvail,et al.  Epoxyeicosatrienoic acids relax airway smooth muscles and directly activate reconstituted KCa channels. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[21]  J. Goldstein,et al.  Cloning and expression of murine CYP2Cs and their ability to metabolize arachidonic acid. , 1998, Archives of biochemistry and biophysics.

[22]  D. Kroetz,et al.  Inhibition of renal arachidonic acid ω-hydroxylase activity with ABT reduces blood pressure in the SHR. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[23]  T. Iwamoto,et al.  Differential inhibition of Na+/Ca2+exchanger isoforms by divalent cations and isothiourea derivative. , 1998, American journal of physiology. Cell physiology.

[24]  E. Jacobs,et al.  Tissue sources of cytochrome P450 4A and 20-HETE synthesis in rabbit lungs. , 1998, American journal of respiratory cell and molecular biology.

[25]  Peter Jönsson,et al.  Characterization of Endothelium- Dependent Relaxation in Guinea Pig Basilar Artery – Effect of Hypoxia and Role of Cytochrome P450 Mono-Oxygenase , 1998, Journal of Vascular Research.

[26]  P. Pratt,et al.  Bioassay of an Endothelium-Derived Hyperpolarizing Factor from Bovine Coronary Arteries: Role of a Cytochrome P450 Metabolite , 1998, Journal of Vascular Research.

[27]  J. Lasker,et al.  Metabolism of arachidonic acid to 20-hydroxy-5,8,11, 14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11. , 1998, The Journal of pharmacology and experimental therapeutics.

[28]  Xiaohong Wang,et al.  Nitric oxide increases the activity of the apical 70-pS K+ channel in TAL of rat kidney. , 1998, American journal of physiology. Renal physiology.

[29]  M. Paillard,et al.  ANG II controls Na+-K+([Formula: see text])-2Cl-cotransport via 20-HETE and PKC in medullary thick ascending limb. , 1998, American journal of physiology. Cell physiology.

[30]  C. Magyar,et al.  The cytochrome P-450 inhibitor cobalt chloride prevents inhibition of renal Na,K-ATPase and redistribution of apical NHE-3 during acute hypertension. , 1998, Journal of the American Society of Nephrology : JASN.

[31]  D. Harder,et al.  Cat cerebral arterial smooth muscle cells express cytochrome P450 4A2 enzyme and produce the vasoconstrictor 20‐HETE which enhances L‐type Ca2+ current , 1998, The Journal of physiology.

[32]  J. Falck,et al.  20-HETE mediates the effect of parathyroid hormone and protein kinase C on renal phosphate transport. , 1998, Prostaglandins, leukotrienes, and essential fatty acids.

[33]  J. Falck,et al.  Cytochrome P450-derived arachidonic acid metabolism in the rat kidney: characterization of selective inhibitors. , 1998, The Journal of pharmacology and experimental therapeutics.

[34]  R. Roman,et al.  Localization of cytochrome P-450 4A isoforms along the rat nephron. , 1998, American journal of physiology. Renal physiology.

[35]  D. Harder,et al.  20-Hydroxyeicosatetraenoic Acid-induced Vasoconstriction and Inhibition of Potassium Current in Cerebral Vascular Smooth Muscle Is Dependent on Activation of Protein Kinase C* , 1997, The Journal of Biological Chemistry.

[36]  P. Angeli,et al.  Eicosanoid excretion in hepatic cirrhosis. Predominance of 20-HETE. , 1997, The Journal of clinical investigation.

[37]  J. Imig,et al.  Afferent arteriolar responses to ANG II involve activation of PLA2 and modulation by lipoxygenase and P-450 pathways. , 1997, The American journal of physiology.

[38]  W. Campbell,et al.  Epoxyeicosatrienoic acids activate K+ channels in coronary smooth muscle through a guanine nucleotide binding protein. , 1997, Circulation research.

[39]  J. Voorde,et al.  Evidence Against the Involvement of Cytochrome P450 Metabolites in Endothelium‐Dependent Hyperpolarization of the Rat Main Mesenteric Artery , 1997, The Journal of physiology.

[40]  K. Tomer,et al.  Molecular Cloning, Expression, and Functional Significance of a Cytochrome P450 Highly Expressed in Rat Heart Myocytes* , 1997, The Journal of Biological Chemistry.

[41]  P. Greengard,et al.  20-Hydroxyeicosa-tetraenoic acid (20 HETE) activates protein kinase C. Role in regulation of rat renal Na+,K+-ATPase. , 1997, Journal of Clinical Investigation.

[42]  C. Ackerley,et al.  Carbon monoxide formation in the ductus arteriosus in the lamb: implications for the regulation of muscle tone , 1997, British journal of pharmacology.

[43]  J. Grider,et al.  P450 arachidonate metabolites mediate bradykinin-dependent inhibition of NaCl transport in the rat thick ascending limb. , 1997, Canadian journal of physiology and pharmacology.

[44]  R. Roman,et al.  Cloning, sequencing, and cDNA-directed expression of the rat renal CYP4A2: arachidonic acid omega-hydroxylation and 11,12-epoxidation by CYP4A2 protein. , 1996, Archives of biochemistry and biophysics.

[45]  L. Navar,et al.  Actions of epoxygenase metabolites on the preglomerular vasculature. , 1996, Journal of the American Society of Nephrology : JASN.

[46]  J. Falck,et al.  Cytochrome P450, the arachidonic acid cascade, and hypertension: new vistas for an old enzyme system , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[47]  A. Hudetz,et al.  Inhibition of brain P-450 arachidonic acid epoxygenase decreases baseline cerebral blood flow. , 1996, The American journal of physiology.

[48]  R. A. Johnson,et al.  Heme oxygenase substrates acutely lower blood pressure in hypertensive rats. , 1996, The American journal of physiology.

[49]  R. Roman,et al.  Identification of a putative microvascular oxygen sensor. , 1996, Circulation research.

[50]  H. Jacob,et al.  Renal cytochrome P4504A activity and salt sensitivity in spontaneously hypertensive rats. , 1996, Hypertension.

[51]  K. Tomer,et al.  Biochemical characterization of the human liver cytochrome P450 arachidonic acid epoxygenase pathway. , 1996, Archives of biochemistry and biophysics.

[52]  R. Roman,et al.  Molecular characterization of an arachidonic acid epoxygenase in rat brain astrocytes. , 1996, Stroke.

[53]  E. Jacobs,et al.  Stereospecific effects of epoxyeicosatrienoic acids on renal vascular tone and K(+)-channel activity. , 1996, The American journal of physiology.

[54]  R. Roman,et al.  Cytochrome P4504A genotype cosegregates with hypertension in Dahl S rats. , 1996, Hypertension.

[55]  P. Pratt,et al.  Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. , 1996, Circulation research.

[56]  M. Bihoreau,et al.  Genetic mapping of two blood pressure quantitative trait loci on rat chromosome 1. , 1996, The Journal of clinical investigation.

[57]  D W Nebert,et al.  P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. , 1996, Pharmacogenetics.

[58]  J. Falck,et al.  20-Hydroxyeicosatetraenoic acid is formed in response to EGF and is a mitogen in rat proximal tubule. , 1995, The American journal of physiology.

[59]  D. Waxman,et al.  Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes. , 1995, Archives of biochemistry and biophysics.

[60]  R. Miller,et al.  The rabbit pulmonary cytochrome P450 arachidonic acid metabolic pathway: characterization and significance. , 1995, The Journal of clinical investigation.

[61]  R. A. Johnson,et al.  A heme oxygenase product, presumably carbon monoxide, mediates a vasodepressor function in rats. , 1995, Hypertension.

[62]  H. Jacobson,et al.  Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induce hypertension in rats fed a high salt diet. , 1994, The Journal of clinical investigation.

[63]  R. Busse,et al.  Characterization of endothelium‐derived hyperpolarizing factor as a cytochrome P450‐derived arachidonic acid metabolite in mammals. , 1994, The Journal of physiology.

[64]  D. Koop,et al.  Regio- and stereoselective epoxidation of arachidonic acid by human cytochromes P450 2C8 and 2C9. , 1994, The Journal of pharmacology and experimental therapeutics.

[65]  A. Nanji,et al.  Changes in cytochromes P-450, 2E1, 2B1, and 4A, and phospholipases A and C in the intragastric feeding rat model for alcoholic liver disease: relationship to dietary fats and pathologic liver injury. , 1994, Alcoholism, clinical and experimental research.

[66]  R. Roman,et al.  Altered renal P-450 metabolism of arachidonic acid in Dahl salt-sensitive rats. , 1994, The American journal of physiology.

[67]  P. Ortiz de Montellano,et al.  Effect of P-450 omega-hydroxylase metabolites of arachidonic acid on tubuloglomerular feedback. , 1994, The American journal of physiology.

[68]  J. Halpert,et al.  Epoxidation of arachidonic acid as an active-site probe of cytochrome P-450 2B isoforms. , 1994, Biochimica et biophysica acta.

[69]  R. Roman,et al.  Formation and action of a P-450 4A metabolite of arachidonic acid in cat cerebral microvessels. , 1994, The American journal of physiology.

[70]  P. Ortiz de Montellano,et al.  Cytochrome P-450 inhibitors alter afferent arteriolar responses to elevations in pressure. , 1994, The American journal of physiology.

[71]  R. Cohen,et al.  Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle , 1994, Nature.

[72]  W. Garland,et al.  A 13-week toxicologic and pathologic evaluation of prolonged cytochromes P450 inhibition by 1-aminobenzotriazole in male rats. , 1994, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[73]  J. Falck,et al.  Parathyroid hormone inhibits Na(+)-K(+)-ATPase through a cytochrome P-450 pathway. , 1994, The American journal of physiology.

[74]  J. Falck,et al.  Elevated renovascular tone in young spontaneously hypertensive rats. Role of cytochrome P-450. , 1993, Hypertension.

[75]  R. Roman,et al.  Clofibrate prevents the development of hypertension in Dahl salt-sensitive rats. , 1993, Hypertension.

[76]  J. Bend,et al.  Dose-dependent, mechanism-based inactivation of cytochrome P450 monooxygenases in vivo by 1-aminobenzotriazole in liver, lung, and kidney of untreated, phenobarbital-treated, and beta-naphthoflavone-treated guinea pigs. , 1992, Canadian journal of physiology and pharmacology.

[77]  J. García-Sancho,et al.  High affinity inhibition of Ca(2+)-dependent K+ channels by cytochrome P-450 inhibitors. , 1992, The Journal of biological chemistry.

[78]  J. García-Sancho,et al.  Inhibition of voltage‐gated Ca2+ entry into GH3 and chromaffin cells by imidazole antimycotics and other cytochrome P450 blockers , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[79]  D. Koop,et al.  Purification and properties of a cytochrome P450 arachidonic acid epoxygenase from rabbit renal cortex. , 1992, The Journal of biological chemistry.

[80]  D. Waxman,et al.  Sex-dependent expression and clofibrate inducibility of cytochrome P450 4A fatty acid omega-hydroxylases. Male specificity of liver and kidney CYP4A2 mRNA and tissue-specific regulation by growth hormone and testosterone. , 1992, The Journal of biological chemistry.

[81]  J. Douglas,et al.  An epoxygenase metabolite of arachidonic acid mediates angiotensin II-induced rises in cytosolic calcium in rabbit proximal tubule epithelial cells. , 1991, The Journal of clinical investigation.

[82]  J. Falck,et al.  Effect of cytochrome P450 arachidonate metabolites on ion transport in rabbit kidney loop of Henle. , 1991, Science.

[83]  N. Iwai,et al.  Isolation of Preferentially Expressed Genes in the Kidneys of Hypertensive Rats , 1991, Hypertension.

[84]  H. Jacobson,et al.  Epoxyeicosatrienoic acids activate Na+/H+ exchange and are mitogenic in cultured rat glomerular mesangial cells , 1990, Journal of cellular physiology.

[85]  G. FitzGerald,et al.  Endogenous biosynthesis of arachidonic acid epoxides in humans: increased formation in pregnancy-induced hypertension. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[86]  G. Gibson.  Comparative aspects of the mammalian cytochrome P450 IV gene family. , 1989, Xenobiotica; the fate of foreign compounds in biological systems.

[87]  S. Imaoka,et al.  Induction of renal cytochrome P-450 in hepatic microsomes of diabetic rats. , 1988, Biochemical and biophysical research communications.

[88]  H. Jacobson,et al.  Renal microsomal cytochrome P-450 and the oxidative metabolism of arachidonic acid. , 1988, The American journal of the medical sciences.

[89]  L. Marnett,et al.  Inhibitors of cytochrome P-450-dependent arachidonic acid metabolism. , 1988, Archives of biochemistry and biophysics.

[90]  A. D. Rodrigues,et al.  Interactions of imidazole antifungal agents with purified cytochrome P-450 proteins. , 1987, Biochemical pharmacology.

[91]  P. Ortiz de Montellano,et al.  Leukotriene B4 omega-hydroxylase in human polymorphonuclear leukocytes. Suicidal inactivation by acetylenic fatty acids. , 1985, The Journal of biological chemistry.

[92]  M. Schwartzman,et al.  Renal cytochrome P450-related arachidonate metabolite inhibits (Na+ + K+)ATPase , 1985, Nature.

[93]  R. Roman,et al.  Role of 20-HETE in elevating chloride transport in the thick ascending limb of Dahl SS/Jr rats. , 1999, Hypertension.

[94]  E. Inscho,et al.  Afferent arteriolar vasodilation to the sulfonimide analog of 11, 12-epoxyeicosatrienoic acid involves protein kinase A. , 1999, Hypertension.

[95]  Chengwen Sun,et al.  Role of tyrosine kinase and PKC in the vasoconstrictor response to 20-HETE in renal arterioles. , 1999, Hypertension.

[96]  R. Roman,et al.  Induction of P4504A activity improves pressure-natriuresis in Dahl S rats. , 1998, Hypertension.

[97]  K. Malik,et al.  Cytochrome P-450 metabolites mediate norepinephrine-induced mitogenic signaling. , 1998, Hypertension.

[98]  R. Wang,et al.  Resurgence of carbon monoxide: an endogenous gaseous vasorelaxing factor. , 1998, Canadian journal of physiology and pharmacology.

[99]  H. Drummond,et al.  Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide. , 1997, Hypertension.

[100]  R. Roman,et al.  Inhibition of renal outer medullary 20-HETE production produces hypertension in Lewis rats. , 1997, Hypertension.

[101]  K. Pritchard,et al.  Human umbilical vein endothelial cells express P450 2C8 mRNA : cloning of endothelial P450 epoxygenase , 1996 .

[102]  J. Falck,et al.  Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. , 1996, The American journal of physiology.

[103]  E. Jacobs,et al.  20-HETE is an endogenous inhibitor of the large-conductance Ca(2+)-activated K+ channel in renal arterioles. , 1996, The American journal of physiology.

[104]  P. Ortiz de Montellano,et al.  Effects of 17-octadecynoic acid, a suicide-substrate inhibitor of cytochrome P450 fatty acid omega-hydroxylase, on renal function in rats. , 1994, The Journal of pharmacology and experimental therapeutics.

[105]  N. Abraham,et al.  Age-related changes in renal cytochrome P-450 arachidonic acid metabolism in spontaneously hypertensive rats. , 1992, The American journal of physiology.

[106]  J. M. Bailey,et al.  Prostaglandins, Leukotrienes, Lipoxins, and PAF , 1991, GWUMC Department of Biochemistry Annual Spring Symposia.

[107]  P. Angeli,et al.  Increased renal production of cytochrome P450-dependent metabolites of arachidonic acid in cyclosporine-induced nephrotoxicity. , 1991, Advances in prostaglandin, thromboxane, and leukotriene research.